Why Healthcare Investors Shouldn't Bank On Drug Pipelines

featured-image

Floortje Healthcare companies often grab headlines for their exciting drug innovations. But we think the focus should be on business fundamentals. Healthcare stocks can conjure up images of clinical trials, blockbuster drugs and supersized marketing campaigns.

But that’s a one-dimensional way.